These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 26249767

  • 1. Once-daily dosing of levocabastine has comparable efficacy to twice-daily dosing in the treatment of allergic rhinitis assessed in an allergen challenge chamber.
    Murdoch RD, Bareille P, Ignar D, Mark S, Miller SR, Gupta A, Salapatek AM, Patel P.
    Int J Clin Pharmacol Ther; 2015 Oct; 53(10):811-8. PubMed ID: 26249767
    [Abstract] [Full Text] [Related]

  • 2. The improved efficacy of a fixed-dose combination of fluticasone furoate and levocabastine relative to the individual components in the treatment of allergic rhinitis.
    Murdoch RD, Bareille P, Ignar D, Miller SR, Gupta A, Boardley R, Zieglmayer P, Zieglmayer R, Lemel P, Horak F.
    Clin Exp Allergy; 2015 Aug; 45(8):1346-55. PubMed ID: 25900517
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics, Safety, and Tolerability of Once-Daily Intranasal Fluticasone Furoate and Levocabastine Administered Alone or Simultaneously as fluticasone Furoate/Levocabastine Fixed-Dose Combination.
    Allen A, Murdoch RD, Bareille P, Burns O, Hughes S, Gupta A, Miller SR.
    Clin Pharmacol Drug Dev; 2016 May; 5(3):225-31. PubMed ID: 27163502
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R, Bilastine International Working Group.
    Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
    [Abstract] [Full Text] [Related]

  • 5. Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber.
    Zieglmayer P, Zieglmayer R, Bareille P, Rousell V, Salmon E, Horak F.
    Curr Med Res Opin; 2008 Jun; 24(6):1833-40. PubMed ID: 18498678
    [Abstract] [Full Text] [Related]

  • 6. A multicenter randomized double-blind 2-week comparison study of azelastine nasal spray 0.1% versus levocabastine nasal spray 0.05% in patients with moderate-to-severe allergic rhinitis.
    Han D, Chen L, Cheng L, Liu S, Fu Z, Zhang W, Wang C, Xi L, Zhang L, Chinese Allergic Rhinitis Collaborative Research Group (C2AR2G).
    ORL J Otorhinolaryngol Relat Spec; 2011 Jun; 73(5):260-5. PubMed ID: 21832863
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis.
    Korsgren M, Andersson M, Borgå O, Larsson L, Aldén-Raboisson M, Malmqvist U, Greiff L.
    Ann Allergy Asthma Immunol; 2007 Apr; 98(4):316-21. PubMed ID: 17458426
    [Abstract] [Full Text] [Related]

  • 8. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
    Berger W, Hampel F, Bernstein J, Shah S, Sacks H, Meltzer EO.
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group.
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
    Jacobs R, Martin B, Hampel F, Toler W, Ellsworth A, Philpot E.
    Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
    [Abstract] [Full Text] [Related]

  • 11. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber.
    Nolte H, Maloney J, Nelson HS, Bernstein DI, Lu S, Li Z, Kaur A, Zieglmayer P, Zieglmayer R, Lemell P, Horak F.
    J Allergy Clin Immunol; 2015 Jun; 135(6):1494-501.e6. PubMed ID: 25636947
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
    Falser N, Wober W, Rahlfs VW, Baehre M.
    Arzneimittelforschung; 2001 Jun; 51(5):387-93. PubMed ID: 11413739
    [Abstract] [Full Text] [Related]

  • 13. The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis.
    Bareille P, Murdoch RD, Denyer J, Bentley J, Smart K, Yarnall K, Zieglmayer P, Zieglmayer R, Lemell P, Horak F.
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):576-84. PubMed ID: 23735181
    [Abstract] [Full Text] [Related]

  • 14. Dose-dependent effects of budesonide aqueous nasal spray on symptoms in a daily nasal allergen challenge model.
    Andersson M, Svensson C, Persson C, Akerlund A, Greiff L.
    Ann Allergy Asthma Immunol; 2000 Oct; 85(4):279-83. PubMed ID: 11061470
    [Abstract] [Full Text] [Related]

  • 15. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C.
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
    Torkildsen GL, Gomes P, Welch D, Gopalan G, Srinivasan S.
    Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
    [Abstract] [Full Text] [Related]

  • 17. Intranasal levocabastine provides fast and effective protection from nasal allergen challenge.
    Bachert C, Wagenmann M, Vossen-Holzenkamp S.
    Rhinology; 1996 Sep; 34(3):140-3. PubMed ID: 8938880
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis.
    Hampel F, Howland W, Van Bavel J, Ratner P.
    J Investig Allergol Clin Immunol; 2004 Sep; 14(1):56-63. PubMed ID: 15160443
    [Abstract] [Full Text] [Related]

  • 19. Intranasal levocabastine for the treatment of seasonal allergic rhinitis: a multicentre, double-blind, placebo-controlled trial.
    Dahl R, Pedersen B, Larsen B.
    Rhinology; 1995 Sep; 33(3):121-5. PubMed ID: 8560160
    [Abstract] [Full Text] [Related]

  • 20. Levocabastine nasal spray significantly improves perennial allergic rhinitis: a single-blind placebo-controlled study.
    Okubo K, Uchida E, Nogami S.
    Auris Nasus Larynx; 2010 Aug; 37(4):436-42. PubMed ID: 20138720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.